SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

Ligence Heart

by Ligence

AI Verdict

SensiCardiac Mobi focuses on AI-powered analysis of acoustic heart signals from stethoscopes to differentiate heart murmurs. In contrast, Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography imaging data. While both are FDA-cleared AI tools for cardiology, their distinct input modalities and diagnostic applications mean they serve different stages and types of cardiac assessment.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you need an immediate, AI-assisted screening tool at the point of care to differentiate between physiological and pathological heart murmurs using an electronic stethoscope. This mobile application is ideal for physicians in primary care, internal medicine, or pediatrics who require quick decision support for initial cardiac auscultation findings.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department or echocardiography lab requires automated, in-depth analysis and reporting of 2D transthoracic echocardiography images. This web-based platform is best suited for enhancing diagnostic efficiency and accuracy by automating complex measurements, view classifications, and disease recognition from echocardiogram data.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Ligence Heart
Pricing	Contact for pricing	Contact-for-pricing
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based; on-premise; hybrid
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A, SensiCardiac Mobi, offers a mobile application interface for data capture and display, making it highly portable and potentially more intuitive for real-time, on-the-go heart murmur analysis. This direct, mobile-first approach for a specific diagnostic task suggests a streamlined user experience compared to a broader web-based platform.

Clinical Value

Ligence Heart

Tool B, Ligence Heart, provides automated analysis and reporting of 2D transthoracic echocardiography, covering a wider range of measurements, view classifications, and disease recognition (e.g., heart failure, cardiomyopathy). While both are FDA-cleared, Ligence Heart's comprehensive automation of a complex diagnostic workflow offers a broader and potentially more significant impact on diagnostic efficiency and accuracy across multiple cardiac conditions.

Pricing & Value

Tie

Both tools, SensiCardiac Mobi and Ligence Heart, require direct contact with the vendor for pricing information, with no public details available. Without transparent pricing structures or specific cost-benefit analyses, it is impossible to determine which offers better value.

Enterprise Readiness

Ligence Heart

Ligence Heart offers flexible deployment options including cloud-based, on-premise, and hybrid, and explicitly states integration capabilities with existing systems like PACS, EHR, and RIS. This comprehensive approach to deployment and integration makes it more adaptable and ready for diverse enterprise healthcare environments compared to Tool A's hosted server environment with a mobile application.

Innovation

Ligence Heart

While SensiCardiac Mobi innovates with AI-powered mobile auscultation for heart murmurs, Ligence Heart's innovation in automating the entire 2D transthoracic echocardiography analysis and reporting workflow, including complex measurements and disease recognition, represents a broader and more transformative application of AI in cardiology. Automating such a detailed and time-consuming diagnostic process offers significant advancements in efficiency and accuracy.

Support & Docs

Tie

The provided structured facts do not contain any information regarding support services or documentation for either SensiCardiac Mobi or Ligence Heart. Publicly available information on these aspects is also not readily apparent through general web searches. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Ligence Heart
Tool Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Ligence Heart
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Ligence
Primary Diagnostic Focus	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Automates the analysis and reporting of 2D transthoracic echocardiography.
Input Data Type	Acoustic heart signals from an electronic stethoscope	2D transthoracic echocardiography imaging data
Key Analytical Capabilities	Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm; Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs.	Automated recognition of echocardiography imaging data; Automated view classification and heart phase prediction; Automated calculation of measurements and report generation; Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases).
Specialties Supported	Cardiology, Internal Medicine, Pediatrics	Cardiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Ligence Heart.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into a physician's existing clinical workflow for patient assessment and diagnosis?

SensiCardiac Mobi is designed for point-of-care use, assisting physicians in real-time by analyzing acoustic heart signals from an electronic stethoscope to differentiate heart murmurs. It functions as decision support during auscultation, complementing the physician's assessment. Ligence Heart integrates into the post-acquisition workflow of echocardiography, automating the analysis and reporting of 2D transthoracic echocardiograms. It streamlines the process for cardiologists and sonographers by generating automated measurements and reports.

What level of integration can be expected with existing electronic health record (EHR) systems for each tool?

SensiCardiac Mobi's description does not explicitly detail direct EHR integration, focusing on its mobile application for data capture and display. Physicians would likely need to manually transfer relevant findings into the EHR. Ligence Heart is designed for robust integration with existing hospital systems, including PACS, EHR, and RIS, facilitating the transfer of echocardiography images and automated reports. This allows for a more seamless flow of diagnostic information into the patient's record.

For which specific clinical scenarios or patient populations is each tool best suited, considering their distinct functionalities?

SensiCardiac Mobi is well-suited for general practitioners, internists, and pediatricians, as well as cardiologists, who need assistance in the initial screening and differentiation of physiological versus pathological heart murmurs. It supports the assessment of heart sounds at the point of care. Ligence Heart is primarily tailored for cardiologists and sonographers in echocardiography labs, focusing on the detailed, automated analysis of 2D transthoracic echocardiograms for adult patients in sinus rhythm. It aids in the diagnosis of conditions like heart failure, cardiomyopathy, and valvular heart diseases.

What specific diagnostic assistance or clinical insights do these tools provide regarding accuracy and the types of conditions they help identify?

SensiCardiac Mobi analyzes heart sounds using its algorithm to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs. It functions as decision support to complement a physician's assessment. Ligence Heart automates the recognition of echocardiography imaging data, performs calculations for measurements (Area, Distance, Doppler, Volume), and aids in disease recognition for conditions such as heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases. It aims to enhance diagnostic efficiency and accuracy in echocardiography.

Do these tools offer features for tracking usage, data analysis, or decisions for auditing and quality assurance purposes?

The provided information for SensiCardiac Mobi does not explicitly detail audit-trail features for tracking usage or specific diagnostic decisions. Ligence Heart's instructions for use mention 'Auditing' as part of its post-market follow-up activities to ensure internal and external views are monitored. It also notes that the software database is not accessible to the user, preventing access to system log files.

What are the key considerations for deploying each tool across multiple clinical sites or departments within a healthcare system?

For SensiCardiac Mobi, multi-site rollout would involve provisioning compatible electronic stethoscopes and iPhone devices for each physician or department, along with managing access to its hosted server environment. Ligence Heart, with its cloud-based, on-premise, or hybrid deployment options and explicit integration with PACS, EHR, and RIS, appears designed for more flexible and scalable enterprise-wide deployments across multiple sites.